NF

Navin Fluorine International Ltd

Q4 FY25Chemicals & Petrochemicals

Navin Fluorine International Ltd Q4 FY25 Results & Concall Highlights: Revenue, Margins & Order Book

Q4 FY25 earnings call: what management guided on revenue, margins and order book.

Price8,206
Market cap₹42.3K Cr
P/E53.1
Updated23 Aug 2026
Read5 min read

The short version

Navin Fluorine aims to grow its CDMO business to $100 million revenue by FY '27, supported equally by existing contracts, new MSAs, and base business. Navin Fluorine targets to maintain an Operating EBITDA margin around 25% (between 23%-27%) for FY '26, striving for stability amid market uncertainties.

From Navin Fluorine International Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Navin Fluorine aims to grow its CDMO business to $100 million revenue by FY '27, supported equally by existing contracts, new MSAs, and base business.
  • The company sees strong growth in the liquid cooling market, expected to grow from $0.5 billion today to $3 billion by 2035, including two-phase immersion cooling liquids.
  • Fluoro specialty project (INR 540 crores capex) is ramping up with 50-55% utilization expected by end FY '26, contributing to revenue growth.
  • New capacity for R32 refrigerant is servicing global markets, with healthy pricing and strategic partnerships in discussion.
  • cGMP4 phase 1 capex (INR 160 crores) for CDMO business is on track for end of Q3 FY '26 commissioning, enabling further capacity expansion.
  • Overall revenue growth driven by product diversification, capacity expansions, and increasing repeat orders in CDMO and specialty chemicals.

Profitability & Margins

See what Navin Fluorine International Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

- Fluoro Specialty Project: Commercial production started Dec 2024 at Dahej facility; ramping up well. - Surat Expansion: INR 30 crores expansion initiated dispatches from Feb 2025. - cGMP4 Capex: INR 288 crores planned; Phase 1 (INR 160 crores) on track for commissioning by Q3 FY '26. - Opteon Project with Chemours: $14 million capex; initial capacity set up to accelerate market adoption, with potential for further capacity expansion. - CDMO Business: Strategic investment with capex run rate approx. INR 500-600 crores for FY '26. - Margins targeted at around 25% with ongoing efforts. - Partnership Importance: Chemours' $5 million co-investment symbolic for partnership and strategy, despite Navin's capacity to fully fund. - Growth Focus: Continuing targeted capital investments aligned with market evolution and strategic priorities. Overall, investments focus on capacity ramp-up, new technologies (advanced materials like immersion cooling liquids), and scaling CDMO capabilities.

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Navin Fluorine International Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • Navin Fluorine is working on 10 to 15 commercial or late-stage products in the CDMO vertical with growth potential.
  • A commercial order from a U.S. major is expected for delivery in FY '26, following a successful scale-up order delivered in Q4 FY '25.
  • Multiple inquiries for R32 capacity came much before the capacity became operational, indicating strong demand.
  • Discussions with global majors for strategic partnerships on new capacities are ongoing.
  • The initial production capacity for Opteon is sufficient to support several field trials to accelerate market adoption.
  • The partnership with Chemours is aimed at scaling production as adoption of two-phase immersion cooling liquids grows.
  • Overall, order inflow is robust across product lines and geographies, supporting growth targets into FY '26 and FY '27.

Navin Fluorine International Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹938 Cr, net profit ₹213 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Clean Science (Q4 FY25)

    2,500 crores to Rs. Key concall takeaways from Clean Science's Q4 FY25 earnings call — and how it ranks against sector peers.

  • Yasho Industries (Q4 FY25)

    Exports continue to be a key revenue driver, contributing around 67% of total revenue. Key concall takeaways from Yasho Industries's Q4 FY25 earnings call…

  • Vinati Organics (Q4 FY25)

    Overall growth supported by strategic capex (~INR360 crores in FY26), innovation, and operational efficiencies. Key concall takeaways from Vinati Organics's Q4…

  • PCBL Chemical (Q4 FY25)

    Export sales volume for Carbon Black grew strongly by 16.8% in Q4 FY'25, reflecting strong international demand. Key concall takeaways from PCBL Chemical's Q4…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Navin Fluorine International Ltd Q4 FY25 results?

Navin Fluorine aims to grow its CDMO business to $100 million revenue by FY '27, supported equally by existing contracts, new MSAs, and base business. Navin Fluorine targets to maintain an Operating EBITDA margin around 25% (between 23%-27%) for FY '26, striving for stability amid market uncertainties.

What is Navin Fluorine International Ltd share price analysis?

Navin Fluorine International Ltd currently shows a neutral. The stock trades at a P/E of 53.1 with a market cap of ₹42,251 Cr. Investors should review the full earnings analysis for detailed insights.

Is Navin Fluorine International Ltd planning capital expenditure?

Fluoro Specialty Project: Commercial production started Dec 2024 at Dahej facility; ramping up well. - Surat Expansion: INR 30 crores expansion initiated dispatches from Feb 2025. - cGMP4 Capex: INR 288 crores planned; Phase 1 (INR 160 crores) on track for commissioning by Q3 FY '26. - Opteon Project with Chemours: $14 million capex; initial capacity set up to accelerate market adoption, with potential for further capacity expansion. - CDMO Business: Strategic investment with capex run rate approx.

Keep Navin Fluorine International Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.